In vivo near-infrared imaging and phototherapy of tumors using a cathepsin B-activated fluorescent probe.
暂无分享,去创建一个
Juyoung Yoon | K. Nam | Yejin Cho | Dayoung Lee | Xiaoqiang Chen | Haengdueng Jeong | Songyi Lee | Sungsook Yu | Gyoungmi Kim
[1] B. Liu,et al. g-C3N4 Coated Upconversion Nanoparticles for 808 nm Near-Infrared Light Triggered Phototherapy and Multiple Imaging , 2016 .
[2] Jiangli Fan,et al. Recent Development of Chemosensors Based on Cyanine Platforms. , 2016, Chemical reviews.
[3] Song Hu,et al. Gold Nanoparticle Coated Carbon Nanotube Ring with Enhanced Raman Scattering and Photothermal Conversion Property for Theranostic Applications. , 2016, Journal of the American Chemical Society.
[4] Wei Pan,et al. A nuclear targeted dual-photosensitizer for drug-resistant cancer therapy with NIR activated multiple ROS† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c6sc00737f , 2016, Chemical science.
[5] P. Loadman,et al. Proteases in cancer drug delivery. , 2016, Advanced drug delivery reviews.
[6] Peng Huang,et al. Tumor-Specific Formation of Enzyme-Instructed Supramolecular Self-Assemblies as Cancer Theranostics. , 2015, ACS nano.
[7] Chun-Hua Yan,et al. Multifunctional upconversion–nanoparticles–trismethylpyridylporphyrin–fullerene nanocomposite: a near-infrared light-triggered theranostic platform for imaging-guided photodynamic therapy , 2015 .
[8] A. Scherz,et al. Photodynamic Quenched Cathepsin Activity Based Probes for Cancer Detection and Macrophage Targeted Therapy , 2015, Theranostics.
[9] Hao Cheng,et al. Hydrophobic IR780 encapsulated in biodegradable human serum albumin nanoparticles for photothermal and photodynamic therapy. , 2015, Acta biomaterialia.
[10] Jinhui Wu,et al. Activatable photodynamic destruction of cancer cells by NIR dye/photosensitizer loaded liposomes. , 2015, Chemical communications.
[11] Ping Gong,et al. Smart human serum albumin-indocyanine green nanoparticles generated by programmed assembly for dual-modal imaging-guided cancer synergistic phototherapy. , 2014, ACS nano.
[12] Shiran Ferber,et al. Polymeric nanotheranostics for real-time non-invasive optical imaging of breast cancer progression and drug release. , 2014, Cancer letters.
[13] Zhuang Liu,et al. Near-infrared dye bound albumin with separated imaging and therapy wavelength channels for imaging-guided photothermal therapy. , 2014, Biomaterials.
[14] Shiran Ferber,et al. Synthesis and evaluation of new NIR-fluorescent probes for cathepsin B: ICT versus FRET as a turn-ON mode-of-action. , 2014, Bioorganic & medicinal chemistry letters.
[15] J. Ong,et al. Design of a paclitaxel prodrug conjugate for active targeting of an enzyme upregulated in breast cancer cells. , 2014, Molecular pharmaceutics.
[16] U. Weidle,et al. Proteases as activators for cytotoxic prodrugs in antitumor therapy. , 2014, Cancer genomics & proteomics.
[17] Juyoung Yoon,et al. Recent progress in the development of near-infrared fluorescent probes for bioimaging applications. , 2014, Chemical Society reviews.
[18] S. Kemmochi,et al. In vivo imaging of tissue-remodeling activity involving infiltration of macrophages by a systemically administered protease-activatable probe in colon cancer tissues. , 2013, Translational oncology.
[19] M. Bogyo,et al. Improved quenched fluorescent probe for imaging of cysteine cathepsin activity. , 2013, Journal of the American Chemical Society.
[20] Yan-jun Zhong,et al. Cathepsin B-cleavable doxorubicin prodrugs for targeted cancer therapy , 2012, International journal of oncology.
[21] Jianping Zhou,et al. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy. , 2012, Biomaterials.
[22] Juyoung Yoon,et al. Fluorescent chemosensors based on spiroring-opening of xanthenes and related derivatives. , 2012, Chemical reviews.
[23] J. Joyce,et al. Proteolytic networks in cancer. , 2011, Trends in cell biology.
[24] Kalpna Garkhal,et al. Doxorubicin-loaded (PEG)₃-PLA nanopolymersomes: effect of solvents and process parameters on formulation development and in vitro study. , 2011, Molecular pharmaceutics.
[25] Tayyaba Hasan,et al. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. , 2010, Chemical reviews.
[26] Gang Zheng,et al. Activatable photosensitizers for imaging and therapy. , 2010, Chemical reviews.
[27] G. Kroemer,et al. Lysosomal membrane permeabilization in cell death , 2008, Oncogene.
[28] Georges von Degenfeld,et al. Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes. , 2007, Nature chemical biology.
[29] B. Wilson,et al. Photodynamic molecular beacon as an activatable photosensitizer based on protease-controlled singlet oxygen quenching and activation , 2007, Proceedings of the National Academy of Sciences.
[30] R. Weissleder,et al. Selective antitumor effect of novel protease-mediated photodynamic agent. , 2006, Cancer research.
[31] M. Beauchemin,et al. Caspase- and mitochondrial dysfunction-dependent mechanisms of lysosomal leakage and cathepsin B activation in DNA damage-induced apoptosis , 2005, Leukemia.
[32] Bonnie F. Sloane,et al. Cathepsin B and tumor proteolysis: contribution of the tumor microenvironment. , 2005, Seminars in cancer biology.
[33] J. Castro,et al. Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[34] Izabela Berdowska,et al. Cysteine proteases as disease markers. , 2004, Clinica chimica acta; international journal of clinical chemistry.
[35] Vishal Saxena,et al. Degradation kinetics of indocyanine green in aqueous solution. , 2003, Journal of pharmaceutical sciences.
[36] R. Weissleder,et al. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes , 1999, Nature Biotechnology.
[37] Bonnie F. Sloane,et al. Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. , 1994, The American journal of pathology.
[38] Zhengze Yu,et al. d dual-photosensitizer for drug-resistant cancer therapy with NIR activated multiple ROS † , 2016 .
[39] Bonnie F. Sloane,et al. Clinicopathologic significance of cathepsin B immunostaining in transitional neoplasia. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.